Clinical Trials Browser

Phase 2 × INDUSTRY × Therapies, Investigational × Clear all

NCT02404389 2021-01-05

Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients

Phase 2 Completed

82 enrolled 16 charts

Keratosis, Actinic

NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2 Completed

88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections